Trial Profile
A study assessing association between brain amyloidosis and anxiety in subjects with Mild Cognitive Impairment or without cognitive impairments using flutemetamol-F-18 PET scan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Cognition disorders
- Focus Diagnostic use
- 19 Oct 2015 New trial record